Mankind Pharma Limited

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:03 10/03/2026 pm IST			5-day change	1st Jan Change
2,237.70 ^INR	+3.44%		-0.35%	+1.88%

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE

Published on 02/03/2026 at 08:56 pm IST - Modified on 02/03/2026 at 11:51 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Mankind Pharma Q3 and 9 month FY '26 Results Conference Call. [Operator Instructions] Please note

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE
09/02	Mankind Pharma says search and seizure/inspection operation conducted by GST department at Bharat Serums and Vaccines	RE
04/02	IIFL Downgrades Mankind Pharma to Add from Buy, Price Target is INR2,300	MT
03/02	Mankind Pharma Limited, Q3 2026 Earnings Call, Feb 03, 2026
03/02	Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
03/02	Indian drugmaker Mankind Pharma posts higher quarterly profit on strong chronic drugs demand	RE
03/02	Mankind Pharma Q3 consol net profit 4.09 billion rupees	RE
10/12	Mankind Pharma receives tax penalty of 153.2 million rupees	RE
01/12	EQT Shows Interest in Vitabiotics - ET	FW
07/11	India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs	RE
07/11	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR3,100, Keeps at Buy	MT
07/11	India stock benchmarks may open flat as profit-taking to offset trade optimism	RE
06/11	Bliss GVS Pharma Limited Appoints Shreekrushna Joshi as Head - Legal as Senior Management Personnel, Effective November 6, 2025	CI
06/11	Mankind Pharma Limited, Q2 2026 Earnings Call, Nov 06, 2025